Esperion Therapeutics Inc (NASDAQ:ESPR) currently has a daily average trading volume of 5.52M but it saw 5476781 shares traded in last market. With a market cap of 221.98M USD, the company’s current market price of $1.12 came rising about 6.67 while comparing to the previous closing price of $1.05. In past 52 weeks, the stock remained buoying in the range of price level as high as $3.94 and as low as $0.69. In the recent trading on the day, stock has struck highest price mark of $1.04 while lowest mark touched by it was $1.13.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Goldman which initiated the stock as “Neutral” in its note to investors issued on December 18, 2024, recommending a price target of $4 for it. BofA Securities issued its recommendations for the stock as it downgraded the price target for the stock is $2.50.
Over the week, ESPR’s stock price is moving 34.18% up while it is 6.67% when we observe its performance for the past one month. Year-to-date it is -49.09% down and over the past year, the stock is showing a downside performance of -48.15%.
Currently, Esperion Therapeutics Inc’s total number of outstanding shares is 196.66M with 0.58% of that held by the insiders while 59.30% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -288.75%. Stock’s beta reads 0.65. Stock has a price to sale or P/S ratio amounts to 0.86. Its return on asset (ROA) is -43.96% on average.
